Meeting Register Page

Webinar: Novartis Discusses the VIBRANT-HD Trial
Join us for an EHA Webinar in which clinical leaders and Novartis representatives will talk about the VIBRANT-HD trial and the decision to stop development of branaplam in HD, and answer community questions.
Meeting logo
Loading
* Required information